Single Dose Pharmacokinetic (PK) Study
NCT03109756
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Angelman Syndrome
Fragile X Syndrome
Interventions
DRUG:
OV101
Sponsor
Healx AI